产品编号 :
Cas No. :
CAS No. |
2230253-82-2 |
|---|---|
中文名称 |
(R)-4-(4-((1-苯乙基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-基)苯酚盐酸盐 |
英文名称 |
(R)-4-(4-((1-Phenylethyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenol hydrochloride |
别名 |
4-[4-[[(1R)-1-Phenylethyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenol hydrochloride |
标准英文名 |
(R)-4-(4-((1-phenylethyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-6-yl)phenol hydrochloride |
分子式 |
C20H19ClN4O |
分子量 |
366.85 |
精确分子量 |
366.12 |
SMILES |
OC1=CC=C(C=C1)C2=CC3=C(N[C@@H](C4=CC=CC=C4)C)N=CN=C3N2.Cl[H] |
标准SMILES |
Cl.C[C@@H](NC1N=CN=C2NC(=CC=12)C1C=CC(O)=CC=1)C1C=CC=CC=1 |
用途 |
PKI-166 hydrochloride is a potent, selective, and orally bioavailable EGFR tyrosine kinase inhibitor (IC50 = 0.7 nM); it inhibits EGFR autophosphorylation in human pancreatic cancer cells in a dose-dependent manner; enhances gemcitabine-mediated cytotoxicity in vitro; and significantly suppresses pancreatic tumor growth in vivo in L3.6pl xenograft mouse models upon oral administration. |
InChIKey |
ZPTWAAIZEGWMGX-BTQNPOSSSA-N |
|
|
评论 |
|---|